ARTHUR MCGINN: Open Payments
NPI 1861588758 · DELMAR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 46 payments from 9 companies in 2025. Trend: 2023 $215 · 2024 $767 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $335 |
| ABBVIE INC. | 11 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Vanda Pharmaceuticals Inc. | 5 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Braeburn Inc. | 2 | $36 |
| Indivior Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, VRAYLAR, CAPLYTA, FANAPT, REXULTI, Auvelity, BRIXADI, SUBLOCADE.
Industry payments across NY — which companies pay providers there.
